nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—CYP19A1—Tamoxifen—pancreatic cancer	0.846	1	CbGbCtD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—TFF1—pancreatic cancer	0.00744	0.0483	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—NR5A2—pancreatic cancer	0.00701	0.0455	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—RBBP8—pancreatic cancer	0.00561	0.0364	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00554	0.036	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.00506	0.0329	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.00436	0.0283	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—HEY2—pancreatic cancer	0.0042	0.0272	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—HEY1—pancreatic cancer	0.00389	0.0252	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.00384	0.0249	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—SHH—pancreatic cancer	0.00342	0.0222	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.0033	0.0214	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—DAXX—pancreatic cancer	0.00308	0.02	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—GCG—pancreatic cancer	0.00264	0.0171	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.0023	0.0149	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—TSC2—pancreatic cancer	0.00226	0.0146	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—HES1—pancreatic cancer	0.00201	0.0131	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00196	0.0127	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00189	0.0123	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—PPARG—pancreatic cancer	0.0017	0.011	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—HIF1A—pancreatic cancer	0.00169	0.011	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.00167	0.0108	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—KDR—pancreatic cancer	0.00161	0.0105	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—NOTCH1—pancreatic cancer	0.00152	0.00987	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00149	0.00966	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.00146	0.00946	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—RB1—pancreatic cancer	0.00137	0.00891	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00134	0.00872	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.00133	0.00866	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—SRC—pancreatic cancer	0.00127	0.00827	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.00125	0.00814	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—SMAD4—pancreatic cancer	0.00124	0.00803	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—SRC—pancreatic cancer	0.00122	0.00794	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.00118	0.00764	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—pancreatic cancer	0.00115	0.00748	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.00108	0.00702	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.00108	0.00698	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.00106	0.00685	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.00104	0.00677	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CDKN2A—pancreatic cancer	0.00098	0.00636	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—PIK3CA—pancreatic cancer	0.000969	0.00629	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000957	0.00621	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.00093	0.00604	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.000925	0.00601	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000911	0.00591	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—HRAS—pancreatic cancer	0.000896	0.00582	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000896	0.00581	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pancreatic cancer	0.000894	0.0058	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—STAT3—pancreatic cancer	0.00088	0.00571	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—pancreatic cancer	0.000861	0.00559	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.000837	0.00543	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000829	0.00538	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CCND1—pancreatic cancer	0.000828	0.00537	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—RB1—pancreatic cancer	0.000824	0.00535	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CTNNB1—pancreatic cancer	0.00082	0.00532	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.000811	0.00526	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.000796	0.00517	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—AKT1—pancreatic cancer	0.000791	0.00514	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—pancreatic cancer	0.000789	0.00512	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000771	0.00501	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000767	0.00498	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AKT1—pancreatic cancer	0.00076	0.00494	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.00072	0.00467	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—pancreatic cancer	0.000715	0.00464	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.000697	0.00453	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000694	0.0045	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000672	0.00436	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pancreatic cancer	0.000666	0.00433	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000662	0.00429	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—pancreatic cancer	0.00066	0.00428	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.00066	0.00428	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—pancreatic cancer	0.000647	0.0042	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000646	0.00419	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	0.000612	0.00397	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	0.000606	0.00393	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	0.000591	0.00383	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000569	0.0037	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CHD3—pancreatic cancer	0.00055	0.00357	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	0.00055	0.00357	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	0.000548	0.00355	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.00054	0.0035	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000538	0.00349	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	0.000534	0.00347	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000529	0.00343	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	0.000528	0.00343	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000521	0.00338	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.0005	0.00325	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	0.00048	0.00312	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000479	0.00311	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000464	0.00301	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000463	0.003	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR5A2—pancreatic cancer	0.000461	0.00299	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	0.00046	0.00299	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000443	0.00288	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000419	0.00272	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000412	0.00267	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000401	0.0026	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000401	0.0026	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000397	0.00258	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000387	0.00251	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000387	0.00251	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000368	0.00239	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000367	0.00238	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000354	0.0023	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000349	0.00227	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000345	0.00224	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000342	0.00222	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000341	0.00221	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.00034	0.00221	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	0.00034	0.00221	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000334	0.00217	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000333	0.00216	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000332	0.00216	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000329	0.00214	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000322	0.00209	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000321	0.00208	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000314	0.00204	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PRSS1—pancreatic cancer	0.000308	0.002	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000301	0.00195	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000297	0.00193	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000297	0.00193	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000292	0.00189	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.00029	0.00188	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000277	0.0018	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000271	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ARG2—pancreatic cancer	0.000267	0.00173	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000266	0.00173	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000266	0.00173	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MEN1—pancreatic cancer	0.000265	0.00172	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000264	0.00171	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000261	0.00169	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000256	0.00166	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH4—pancreatic cancer	0.000251	0.00163	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000248	0.00161	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000246	0.0016	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000246	0.0016	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HSPA1B—pancreatic cancer	0.000239	0.00155	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TYMP—pancreatic cancer	0.000234	0.00152	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000232	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000227	0.00147	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000226	0.00147	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000223	0.00145	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000219	0.00142	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EZH2—pancreatic cancer	0.000218	0.00141	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH3—pancreatic cancer	0.000213	0.00138	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HSPA1A—pancreatic cancer	0.000202	0.00131	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000193	0.00125	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000192	0.00125	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GLP1R—pancreatic cancer	0.000188	0.00122	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DPYD—pancreatic cancer	0.000185	0.0012	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000185	0.0012	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC2A2—pancreatic cancer	0.000176	0.00114	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000174	0.00113	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000168	0.00109	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SMAD4—pancreatic cancer	0.000161	0.00104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000153	0.000993	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CD44—pancreatic cancer	0.000136	0.000884	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000133	0.000865	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MYC—pancreatic cancer	0.000132	0.000859	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000132	0.000857	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GCG—pancreatic cancer	0.000131	0.000847	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—STK11—pancreatic cancer	0.000123	0.000797	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH1—pancreatic cancer	0.000118	0.000769	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000115	0.000748	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARG—pancreatic cancer	0.000112	0.000725	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TYMS—pancreatic cancer	0.000106	0.000685	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOE—pancreatic cancer	8.58e-05	0.000557	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.13e-05	0.000527	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	7.75e-05	0.000503	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARG—pancreatic cancer	7.48e-05	0.000485	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	6.81e-05	0.000442	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MYC—pancreatic cancer	6.37e-05	0.000414	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	5.94e-05	0.000385	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—pancreatic cancer	5.88e-05	0.000382	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTEN—pancreatic cancer	5.13e-05	0.000333	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—pancreatic cancer	4.42e-05	0.000287	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	3.62e-05	0.000235	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—pancreatic cancer	2.96e-05	0.000192	CbGpPWpGaD
